ClinicalTrials.gg
Status unknownNCT00407316Updated Dec 5, 2006

Quality of Life and Visual Function in Uveitis Patients

An observational study in Anterior Uveitis, Posterior Uveitis and Panuveitis, sponsored by The New York Eye & Ear Infirmary. Status unknown at 1 site in United States. Open to participants aged 18 Years to 95 Years. Per ClinicalTrials.gov, last updated 2006-12-05.

Sponsored by The New York Eye & Ear Infirmary · Observational

The sponsor has not verified this record recently (last verified Dec 2006), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Defined population
Time perspective
Other
Enrollment
50
Ages
18 Years to 95 Years
Sex
All
01

Study summary

The purpose of this study was to measure the quality of visual function and quality of daily living in patients with anterior, posterior, and panuveitis.

Read the detailed description

The National Eye Institute Visual Functioning Questionnaire, version August 2000 (NEI VFQ-25) and the Medical Outcomes Study (MOS) 36 Item Short Form Health Survey Instrument (SF-36) (RAND 36-Item Health Survey 1.0 Questionnaire) will be administered by a trained interviewer. Socio-demographic and clinical data will be collected for additional QOL parameter.

02

Conditions studied

  • Anterior Uveitis
  • Posterior Uveitis
  • Panuveitis
  • Uveitis

Keywords

  • Uveitis
  • Quality of life
  • Visual function
03

In context

Uveitis, Anterior

56 studies on the registry are indexed under Uveitis, Anterior; 9 are open to participants now.

This study's enrollment of 50 is below the median of 77 across 10 observational studies indexed under Uveitis, Anterior.

Browse Uveitis, Anterior studies →

Lead sponsor

The New York Eye & Ear Infirmary is the lead sponsor of 22 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 95 Years
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria:

  • Ability to provide written
  • Subjects of either gender
  • Age greater than or equal to 18 years of age
  • Diagnosed with Uveitis
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Defined population
Time perspective
Other
Enrollment
50 participants
06

Study locations

1 of 1 sites recruiting
  • New York Eye and Ear Infirmary
    New York, New York 10003, United States
    Recruiting
    • Katy W Tai, MA · Contactktai@nyee.edu · 212-979-4251
    • C. Michael Samson, MD · Principal investigator
07

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 5, 2006, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
08

Registry details

Key details

Study ID
NCT00407316
Lead sponsor
The New York Eye & Ear Infirmary
First posted
Dec 5, 2006
Start date
Jun 2006
Completion
Nov 2006
Last update
Dec 5, 2006

Study contacts

Katy W Tai, MA
Contact
ktai@nyee.edu
212-979-4251
C. Michael Samson, MD
principal investigator · New York Eye and Ear Infirmary
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Dec 2006. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion